Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Other financing activities (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Other financing activities came in at -$7.0 million in Q2 2026, up 12.5% year-over-year from -$6.2 million in Q2 2025, and down 250.0% quarter-over-quarter from -$2.0 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Other financing activities (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Other financing activities across 18 years of filings, most recently posting -$7.0 million for Q2 2026.

  • In Q2 2026, Other financing activities rose 12.5% year-over-year to -$7.0 million; the TTM figure through Jun 2026 stood at -$11.0 million (up 42.11% YoY), while the FY2025 annual figure was -$10.0 million, up 9.09% from the prior year.
  • Other financing activities came in at -$7.0 million for Q2 2026 at Bausch Health Companies, down from -$2.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.0 million in Q1 2022 to a low of -$12.0 million in Q3 2022.
  • Average Other financing activities over 5 years is -$3.5 million, with a median of -$2.0 million recorded in 2024.
  • Year-over-year, Other financing activities tumbled 200.0% in 2022 and jumped 88.89% in 2025.
  • Over 5 years, Other financing activities stood at -$1.0 million in 2022, then plunged by 200.0% to -$3.0 million in 2023, then surged by 33.33% to -$2.0 million in 2024, then surged by 50.0% to -$1.0 million in 2025, then slumped by 600.0% to -$7.0 million in 2026.
  • Per Business Quant data, the three most recent Other financing activities figures were -$7.0 million in Q2 2026, -$2.0 million in Q1 2026, and -$1.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.00 Mn
Mar 31, 2026 -2.00 Mn
Dec 31, 2025 -1.00 Mn
Sep 30, 2025 -1.00 Mn
Jun 30, 2025 -8.00 Mn
Dec 31, 2024 -2.00 Mn
Sep 30, 2024 -9.00 Mn
Dec 31, 2023 -3.00 Mn
Sep 30, 2023 -8.00 Mn
Jun 30, 2023 -1.00 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2022 -1.00 Mn
Sep 30, 2022 -12.00 Mn
Jun 30, 2022 1.00 Mn
Mar 31, 2022 1.00 Mn
Dec 31, 2021 1.00 Mn
Sep 30, 2021 -5.00 Mn
Jun 30, 2021 3.00 Mn
Mar 31, 2021 11.00 Mn
Dec 31, 2020 3.00 Mn